Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study.

Cuzick J, Warwick J, Pinney E, Duffy SW, Cawthorn S, Howell A, Forbes JF, Warren RM.

J Natl Cancer Inst. 2011 May 4;103(9):744-52. doi: 10.1093/jnci/djr079. Epub 2011 Apr 11.

PMID:
21483019
[PubMed - indexed for MEDLINE]
Free Article
2.

Tamoxifen, mammographic density, and breast cancer prevention.

Boyd NF.

J Natl Cancer Inst. 2011 May 4;103(9):704-5. doi: 10.1093/jnci/djr115. Epub 2011 Apr 12. No abstract available.

PMID:
21487099
[PubMed - indexed for MEDLINE]
Free Article
3.

Tamoxifen and breast density in women at increased risk of breast cancer.

Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW.

J Natl Cancer Inst. 2004 Apr 21;96(8):621-8.

PMID:
15100340
[PubMed - indexed for MEDLINE]
Free Article
4.

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.

Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N.

J Natl Cancer Inst. 2005 Nov 16;97(22):1652-62.

PMID:
16288118
[PubMed - indexed for MEDLINE]
Free Article
5.

Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.

Decensi A, Robertson C, Guerrieri-Gonzaga A, Serrano D, Cazzaniga M, Mora S, Gulisano M, Johansson H, Galimberti V, Cassano E, Moroni SM, Formelli F, Lien EA, Pelosi G, Johnson KA, Bonanni B.

J Clin Oncol. 2009 Aug 10;27(23):3749-56. doi: 10.1200/JCO.2008.19.3797. Epub 2009 Jul 13.

PMID:
19597031
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.

Powles TJ, Ashley S, Tidy A, Smith IE, Dowsett M.

J Natl Cancer Inst. 2007 Feb 21;99(4):283-90.

PMID:
17312305
[PubMed - indexed for MEDLINE]
Free Article
7.

Tamoxifen therapy for breast cancer and endometrial cancer risk.

Bernstein L, Deapen D, Cerhan JR, Schwartz SM, Liff J, McGann-Maloney E, Perlman JA, Ford L.

J Natl Cancer Inst. 1999 Oct 6;91(19):1654-62.

PMID:
10511593
[PubMed - indexed for MEDLINE]
Free Article
8.

Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).

Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE.

J Natl Cancer Inst. 2006 Jan 18;98(2):110-5.

PMID:
16418513
[PubMed - indexed for MEDLINE]
Free Article
9.

Are breast density and bone mineral density independent risk factors for breast cancer?

Kerlikowske K, Shepherd J, Creasman J, Tice JA, Ziv E, Cummings SR.

J Natl Cancer Inst. 2005 Mar 2;97(5):368-74.

PMID:
15741573
[PubMed - indexed for MEDLINE]
Free Article
10.

Projecting individualized absolute invasive breast cancer risk in African American women.

Gail MH, Costantino JP, Pee D, Bondy M, Newman L, Selvan M, Anderson GL, Malone KE, Marchbanks PA, McCaskill-Stevens W, Norman SA, Simon MS, Spirtas R, Ursin G, Bernstein L.

J Natl Cancer Inst. 2007 Dec 5;99(23):1782-92. Epub 2007 Nov 27. Erratum in: J Natl Cancer Inst. 2008 Aug 6;100(15):1118. J Natl Cancer Inst. 2008 Mar 5;100(5):373.

PMID:
18042936
[PubMed - indexed for MEDLINE]
Free Article
11.

Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer.

Swain SM, Wilson JW, Mamounas EP, Bryant J, Wickerham DL, Fisher B, Paik S, Wolmark N.

J Natl Cancer Inst. 2004 Apr 7;96(7):516-23.

PMID:
15069113
[PubMed - indexed for MEDLINE]
Free Article
12.

Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.

Swerdlow AJ, Jones ME; British Tamoxifen Second Cancer Study Group.

J Natl Cancer Inst. 2005 Mar 2;97(5):375-84.

PMID:
15741574
[PubMed - indexed for MEDLINE]
Free Article
13.

Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial.

Cuzick J, Forbes JF, Sestak I, Cawthorn S, Hamed H, Holli K, Howell A; International Breast Cancer Intervention Study I Investigators.

J Natl Cancer Inst. 2007 Feb 21;99(4):272-82.

PMID:
17312304
[PubMed - indexed for MEDLINE]
Free Article
14.

Tamoxifen in women with breast cancer and mammographic density.

Meggiorini ML, Labi L, Vestri AR, Porfiri LM, Savelli S, De Felice C.

Eur J Gynaecol Oncol. 2008;29(6):598-601.

PMID:
19115686
[PubMed - indexed for MEDLINE]
15.

Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.

Abramson N, Costantino JP, Garber JE, Berliner N, Wickerham DL, Wolmark N.

J Natl Cancer Inst. 2006 Jul 5;98(13):904-10.

PMID:
16818854
[PubMed - indexed for MEDLINE]
Free Article
16.

Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen.

Atkinson C, Warren R, Bingham SA, Day NE.

Cancer Epidemiol Biomarkers Prev. 1999 Oct;8(10):863-6.

PMID:
10548313
[PubMed - indexed for MEDLINE]
Free Article
17.

First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial.

Cuzick J, Forbes J, Edwards R, Baum M, Cawthorn S, Coates A, Hamed A, Howell A, Powles T; IBIS investigators.

Lancet. 2002 Sep 14;360(9336):817-24.

PMID:
12243915
[PubMed - indexed for MEDLINE]
18.

A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers.

Decensi A, Robertson C, Viale G, Pigatto F, Johansson H, Kisanga ER, Veronesi P, Torrisi R, Cazzaniga M, Mora S, Sandri MT, Pelosi G, Luini A, Goldhirsch A, Lien EA, Veronesi U.

J Natl Cancer Inst. 2003 Jun 4;95(11):779-90.

PMID:
12783932
[PubMed - indexed for MEDLINE]
Free Article
19.

Tamoxifen: an enduring star.

Veronesi U, Maisonneuve P, Decensi A.

J Natl Cancer Inst. 2007 Feb 21;99(4):258-60. No abstract available.

PMID:
17312297
[PubMed - indexed for MEDLINE]
Free Article
20.

Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer.

Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP.

J Natl Cancer Inst. 2003 Oct 1;95(19):1467-76.

PMID:
14519753
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk